Witty’s Bonus Slashed As GSK Recovers From China Scandal
Still learning lessons from 2013's bribery scandal and subsequent investigations in China, GlaxoSmithKline's CEO Sir Andrew Witty had his annual bonus for the past year slashed in half.
Still learning lessons from 2013's bribery scandal and subsequent investigations in China, GlaxoSmithKline's CEO Sir Andrew Witty had his annual bonus for the past year slashed in half.